Regis Healthcare Limited (ASX:REG)
Australia · Delayed Price · Currency is AUD 4.710
-0.090 (-1.88%)
Sep 18, 2026, 4:10 PM AEST
Regis Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 1,351 | 1,161 | 1,014 | 780.61 | 725.33 | |
Revenue Growth | 16.30% | 14.52% | 29.90% | 7.62% | 3.42% |
Cost of Revenue | 1,135 | 961.52 | 838.8 | 647.27 | 609.61 |
Gross Profit | 215.91 | 199.77 | 175.25 | 133.34 | 115.72 |
Selling, General & Admin | 88.92 | 89.93 | 88.06 | 76.77 | 66.14 |
Amortization of Goodwill & Intangibles | - | - | 81.38 | 81.38 | 61.04 |
Operating Expenses | 145.18 | 139.74 | 216.14 | 203.24 | 169.25 |
Operating Income | 70.74 | 60.03 | -40.89 | -69.9 | -53.53 |
Interest Expense | -160.62 | -116.43 | -88.61 | -70.85 | -66.68 |
Interest & Investment Income | 160.19 | 118.48 | 85.5 | 63.58 | 62.45 |
Other Non Operating Income (Expenses) | -2.51 | -3.07 | -2.87 | -2.75 | -3.7 |
EBT Excluding Unusual Items | 67.79 | 59 | -46.86 | -79.92 | -61.46 |
Merger & Restructuring Charges | -12.83 | - | - | - | - |
Gain (Loss) on Sale of Assets | 25.45 | 3.43 | 5.06 | 11.65 | - |
Asset Writedown | 1.91 | 4.5 | - | 0.64 | 3.02 |
Other Unusual Items | 1.39 | 4.5 | 13.69 | 27.25 | 3.25 |
Pretax Income | 83.71 | 71.44 | -28.1 | -40.38 | -55.19 |
Income Tax Expense | 28.03 | 22.49 | -6.69 | -11.93 | -16.39 |
Net Income | 55.69 | 48.95 | -21.42 | -28.45 | -38.8 |
Net Income to Common | 55.69 | 48.95 | -21.42 | -28.45 | -38.8 |
Net Income Growth | 13.76% | - | - | - | - |
Shares Outstanding (Basic) | 302 | 301 | 301 | 301 | 301 |
Shares Outstanding (Diluted) | 303 | 304 | 301 | 301 | 301 |
Shares Change | -0.30% | 0.93% | 0.05% | 0.02% | -0.01% |
EPS (Basic) | 0.18 | 0.16 | -0.07 | -0.09 | -0.13 |
EPS (Diluted) | 0.18 | 0.16 | -0.07 | -0.09 | -0.13 |
EPS Growth | 14.09% | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 194.24 | 219.64 | 186.57 | 53.73 | 67.6 |
Free Cash Flow Per Share | 0.64 | 0.72 | 0.62 | 0.18 | 0.23 |
Dividend Per Share | 0.184 | 0.162 | 0.129 | 0.095 | 0.058 |
Dividend Growth | 13.44% | 25.54% | 36.29% | 62.33% | -11.92% |
Gross Margin | 15.99% | 17.20% | 17.28% | 17.08% | 15.95% |
Operating Margin | 5.24% | 5.17% | -4.03% | -8.95% | -7.38% |
Profit Margin | 4.12% | 4.21% | -2.11% | -3.65% | -5.35% |
Free Cash Flow Margin | 14.38% | 18.91% | 18.40% | 6.88% | 9.32% |
EBITDA | 125.51 | 108.56 | 86.22 | 55.19 | 48.59 |
EBITDA Margin | 9.29% | 9.35% | 8.50% | 7.07% | 6.70% |
D&A For EBITDA | 54.77 | 48.53 | 127.11 | 125.09 | 102.12 |
EBIT | 70.74 | 60.03 | -40.89 | -69.9 | -53.53 |
EBIT Margin | 5.24% | 5.17% | -4.03% | -8.95% | -7.38% |
Effective Tax Rate | 33.48% | 31.48% | - | - | - |
Revenue as Reported | 1,540 | 1,292 | 1,118 | 897.61 | 796.95 |